Uncategorized

Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results – Merck

  1. Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results  Merck
  2. Merck beats estimates on fourth-quarter on earnings—but stock slides pre-market on tepid 2025 guidance  Yahoo Finance
  3. Merck’s 2025 revenue outlook falls short as it pauses Gardasil vaccine shipments to China  CNBC
  4. Merck Stock Tumbles on Weak Guidance and Gardasil Sales Slump  Barron’s
  5. Merck temporarily pauses Gardasil shipments to China following sales slowdown  Endpoints News